CRSP Survivor-Bias-Free US Mutual Fund Database
As the provider of the only complete database of both active and inactive mutual funds, CRSP leads the way in mutual fund research. The CRSP Survivor-Bias-Free US Mutual Fund Database serves as a foundation for research and benchmarking for this asset class. The survivor-bias-free nature of the database ensures accurate performance benchmarks and valid analysis.
The CRSP Survivor-Bias-Free US Mutual Fund Database was initially developed by Mark M. Carhart of Goldman Sachs Asset Management for his 1995 dissertation (Chicago Booth) entitled, “Survivor Bias and Persistence in Mutual Fund Performance,” to fill a need for lacking survivor-bias-free data coverage.
Key Features Include:
The database currently contains complete historical information for roughly 39,000 open-ended funds; over 26,000 active, nearly 13,000 delisted. Included are:
- Equity funds
- Taxable and municipal bond funds
- International funds
- Money market funds
- Variable annuity underlying funds
- ETFs and ETNs
- The data begin at varying times between 1962 and 2008 depending on availability and include:
- History of each mutual fund’s name
- Fund investment style
- Fee structure
- Holdings beginning 2003
- Asset allocation
- Daily and monthly total returns
- Daily and monthly net asset values (NAVs)
- Monthly total net assets (TNA)
- Dividends and distributions
- Schedules of rear and front load fees
- Asset class codes
- Management company contact information
- CRSP FUNDNO® – CRSP’s unique fund identifier
Delivery and Format Options
- The database is updated quarterly.
- SAS format on a DVD (ASCII format available upon request)
- Load file procedure provided for use with MySQL or other relational database
- Third party access is provided via the WRDS (Wharton Research Data Services) internet platform (for academic and government subscribers only)
For additional information regarding the CRSP Survivor-Bias-Free US Mutual Funds Database, please contact subscriptions@crsp.ChicagoBooth.edu or call subscriptions at 312-263-6400.